1-6 of 6
Dale Ludwig
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Iomab with Adoptive Cellular Therapy (Iomab-ACT): A Pilot Study of 131-I Apamistamab Followed By CD19-Targeted CAR T-Cell Therapy for Patients with Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia or Diffuse Large B-Cell Lymphoma

Mark B. Geyer, Briana Cadzin, Elizabeth Halton, Peter Kane, Brigitte Senechal, Eileen M. Geoghegan, Vijay Reddy, Mark S. Berger, Dale Ludwig, Neeta Pandit-Taskar, Craig S. Sauter
Journal: Blood
Blood (2021) 138 (Supplement 1): 4810.
https://doi.org/10.1182/blood-2021-144994
Published: 2021
Journal Articles

Lintuzumab-225Ac in Combination with Venetoclax in Relapsed/Refractory AML: Early Results of a Phase I/II Study

Mohamed M. Hegazi, MD, John G. Harpel, MDPhD, Sara Miao, Dale Ludwig, PhD, Mark S. Berger, MD, Gary J. Schiller, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 24–25.
https://doi.org/10.1182/blood-2020-141132
Published: 2020
Journal Articles

Sierra Clinical Trial Dosimetry Results Support Low Dose Anti-CD45 Iodine (131I) Apamistamab [Iomab-B] for Targeted Lymphodepletion Prior to Adoptive Cell Therapy

Rajneesh Nath, MD, Eileen M Geoghegan, Matthew L. Ulrickson, MD, Jennifer A Spross, MA, Renee H Lichtenstein, BA, Sandy Konerth, MS, Darrell R. Fisher, PhD, Qing Liang, PhD, Dale Ludwig, PhD BS, Vijay Reddy, MD PhD, Mark S. Berger, MD, Boglarka Gyurkocza, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1958.
https://doi.org/10.1182/blood-2019-128838
Published: 2019
Journal Articles

Preclinical Development of an Actinium-225-Labeled Antibody Radio-Conjugate Directed Against CD45 for Targeted Conditioning and Radioimmunotherapy

Dale Ludwig, PhD BS, Ruth Bryan, Wojciech Dawicki, PhD, Eileen M Geoghegan, Qing Liang, PhD, Sandesh Seth, MS, MBA, Mamata Gokhale, Mark S. Berger, MD, Vijay Reddy, MD PhD, Ravendra Garg, Kevin Allen, PhD, Ekaterina Dadachova
Journal: Blood
Blood (2019) 134 (Supplement_1): 5601.
https://doi.org/10.1182/blood-2019-128678
Published: 2019
Journal Articles

Supression of FLT3-Expressing Leukemia by a Monoclonal Antibody-Auristatin Conjugate.

Yiwen Li, MD, Hongli Li, Mei-Nai Wang, Rajiv Bassi, Dale Ludwig, PhD, Larry Witte, PhD, Zhenping Zhu, MD, PhD, Peter Bohlen, PhD, Damon Meyer, PhD, Angelyn Larkin, Peter Senter, PhD, Daniel Hicklin, PhD
Journal: Blood
Blood (2004) 104 (11): 1788.
https://doi.org/10.1182/blood.V104.11.1788.1788
Published: 2004
Journal Articles

FLT3 ligand causes autocrine signaling in acute myeloid leukemia cells

Rui Zheng, Mark Levis, Obdulio Piloto, Patrick Brown, Brenda R. Baldwin, Norbert C. Gorin, Miloslav Beran, Zhenping Zhu, Dale Ludwig, Dan Hicklin, Larry Witte, Yiwen Li, Donald Small
Journal: Blood
Blood (2004) 103 (1): 267–274.
https://doi.org/10.1182/blood-2003-06-1969
Published: 2004